PDS Biotechnology Corporation
PDSB • NASDAQ
PDS Biotechnology Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Frank K. Bedu-Addo, with a market cap of $37.8M.
CEOFrank K. Bedu-Addo
Market Cap$37.8M
Biotechnology
Healthcare
Employees25.0
Websitepdsbiotech.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for PDS Biotechnology Corporation
Date
Thursday, March 26, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.20
Earnings History
Past 12 earnings reports for PDS Biotechnology Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.19Est: -$0.20 | +5.0% | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.21Est: -$0.24 | +12.5% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.21Est: -$0.25 | +16.0% | — | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.21Est: -$0.28 | +25.0% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.29Est: -$0.28 | -3.6% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.23Est: -$0.34 | +32.4% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.30Est: -$0.37 | +18.9% | - | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$0.35Est: -$0.44 | +20.5% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.35Est: -$0.45 | +22.2% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.37Est: -$0.37 | 0.0% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.32Est: -$0.31 | -3.2% | - | — | 10-Q |
| Mar 28, 2023 | Q4 2022 | -$0.67Est: -$0.29 | -131.0% | - | — | — |